TMS Co., Ltd. (4891) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for TMS Co., Ltd. (4891:JPX), powered by AI.

Current Price
¥120
Sector
Healthcare
What is the TMS Co., Ltd. stock price forecast?

TMS Co., Ltd. is currently trading at ¥120. View real-time AI analysis on Alpha Lenz.

What is TMS Co., Ltd. insider trading activity?

View the latest insider trading data for TMS Co., Ltd. on Alpha Lenz.

What is TMS Co., Ltd.'s P/E ratio?

View TMS Co., Ltd.'s valuation metrics on Alpha Lenz.

TMS Co., Ltd.

JPX · 4891
¥120+3(+2.56%)Market closedJPX regular session 09:00–15:00 JST
Ask about TMS Co., Ltd.'s future dividend policy...
Alpha Chat Insight

TMS Co., Ltd.'s ROE is -21.1%. Explore profitability and growth together.

Ask for details

Company Overview

TMS Co., Ltd. is a prominent entity in the pharmaceutical sector, renowned for its research and development prowess in medical treatments and healthcare solutions. The company focuses on creating innovative therapies and pharmaceutical products aimed at a wide range of medical conditions, playing a critical role in advancing health outcomes. TMS Co., Ltd.'s activities encompass the development and commercialization of both prescription and over-the-counter medications, contributing significantly to the healthcare and life sciences industries. Its operations not only highlight cutting-edge scientific research but also emphasize strategic partnerships and collaborations with global health organizations, enhancing its market presence. With headquarters in Tokyo, Japan, TMS Co., Ltd. serves diverse markets domestically and internationally, underlining its importance as a key player in medical innovation and patient care. This presence in the pharmaceutical industry underscores its commitment to addressing global health challenges through science-driven solutions.

CEOMr. Takuro Wakabayashi
SectorHealthcare
IndustryBiotechnology
Employees18

Company Statistics

FY 2025

Profile

N/AMarket Cap
¥0Revenue
0.00Shares Out
18Employees

Margins

N/AGross
N/AEBITDA
N/AOperating
N/APre-Tax
N/ANet

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

N/ARev 3Yr
N/ARev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-20.06%ROA
-21.06%ROE
-27.56%ROIC

Financial Health

¥2,922,950,000Cash & Cash Equivalents
¥-2,706,169,000Net Debt
7.70%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

TMS Co., Ltd. (ticker: 4891) is a company listed on JPX in the Healthcare sector (Biotechnology). It has approximately 18 employees.

The current price is 120 with a P/E ratio of -x and P/B of -x.

ROE is -21.06%.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
TMS Co., Ltd. (4891) Stock Forecast 2026 ¥120 — Price, Financials & Analyst Targets | Alpha Lenz